Nefopam - Beijing CoSci Med Tech

Drug Profile

Nefopam - Beijing CoSci Med Tech

Latest Information Update: 28 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Beijing CoSci Med-Tech
  • Class Non-opioid analgesics; Small molecules
  • Mechanism of Action Adrenergic receptor agonists; Muscarinic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Pain

Most Recent Events

  • 28 Jul 2016 Chemical structure information added
  • 26 Jul 2016 Preclinical trials in Pain in China (PO, Controlled release)
  • 26 Jul 2016 Preclinical trials in Pain in China (PO, Immediate release)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top